Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

NCT01275196

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Chengdu, Sichuan, China
View Trial Details
Completed

Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response

NCT01043874

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia in Chronic Phase, +12 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Aomori, Japan
View all 20 locations
View Trial Details
Completed

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

NCT01398462

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Asan Medical Center Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details
Completed

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

NCT01254188

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Novartis Investigative Site Algiers, Bouzareah, Algeria
  • Novartis Investigative Site Oran, Algeria
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
View all 100 locations
View Trial Details
Completed

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

NCT01511289

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Local Institution Jakarta, Indonesia
  • Local Institution Batangas, Philippines
  • Local Institution Manila, Philippines
  • Local Institution Busan, South Korea
View all 22 locations
View Trial Details
Completed

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

NCT00002766

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions